ESCITALOPRAM
SANIS HEALTH INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of ESCITALOPRAM in Canada?
A shortage of ESCITALOPRAM 20MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated November 11, 2026), but it has not started yet.
Why is ESCITALOPRAM not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will ESCITALOPRAM be available again?
The manufacturer's estimated resolution date is February 12, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MYLAN-ESCITALOPRAM
MYLAN PHARMACEUTICALS ULC
ESCITALOPRAM
JAMP PHARMA CORPORATION
SANDOZ ESCITALOPRAM
SANDOZ CANADA INCORPORATED
AURO-ESCITALOPRAM
AURO PHARMA INC
Other Products
CIPRALEX -10MG
LUNDBECK CANADA INC
MINT-ESCITALOPRAM
MINT PHARMACEUTICALS INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2027-02-12
~3 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02430126
Strength
20MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ESCITALOPRAM
Tier
Unrated
Last Updated
2026-11-11
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from SANIS HEALTH INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
400MG · DIN 02286262
100MG · DIN 02286246
200MG · DIN 02286254
400MG · DIN 02286564
70MG · DIN 02352966
10MG · DIN 02519844
12.5MG · DIN 02466821
0.50MG · DIN 02349205
0.25MG · DIN 02349191
200MG · DIN 02364336
5MG · DIN 02331284
10MG · DIN 02331292